Greenwood Capital Associates’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-14,617
| Closed | -$1.17M | – | 238 |
|
|
2021
Q1 | $1.17M | Sell |
14,617
-2,313
| -14% | -$181K | 0.18% | 95 |
|
|
2020
Q4 | $1.33M | Sell |
16,930
-3,268
| -16% | -$192K | 0.22% | 83 |
|
|
2020
Q3 | $888K | Sell |
20,198
-3,686
| -15% | -$182K | 0.17% | 87 |
|
|
2020
Q2 | $1.06M | Buy |
23,884
+16,949
| +244% | +$632K | 0.24% | 71 |
|
|
2020
Q1 | $249K | Buy |
+6,935
| New | +$394K | 0.07% | 122 |
|
|
2018
Q2 | – | Sell |
-2,295
| Closed | -$256K | – | 235 |
|
|
2018
Q1 | $256K | Buy |
2,295
+235
| +11% | +$26.3K | 0.06% | 159 |
|
|
2017
Q4 | $212K | Sell |
2,060
-180
| -8% | -$17.9K | 0.05% | 200 |
|
|
2017
Q3 | $211K | Sell |
2,240
-760
| -25% | -$60K | 0.05% | 186 |
|
|
2017
Q2 | $234K | Buy |
3,000
+31
| +1% | +$2.33K | 0.06% | 164 |
|
|
2017
Q1 | $238K | Buy |
2,969
+237
| +9% | +$18.8K | 0.06% | 163 |
|
|
2016
Q4 | $215K | Buy |
+2,732
| New | +$212K | 0.06% | 164 |
|
|
2016
Q3 | – | Sell |
-3,128
| Closed | -$215K | – | 188 |
|
|
2016
Q2 | $215K | Buy |
3,128
+109
| +4% | +$7.52K | 0.07% | 152 |
|
|
2016
Q1 | $215K | Sell |
3,019
-419
| -12% | -$26.3K | 0.07% | 155 |
|
|
2015
Q4 | $214K | Buy |
+3,438
| New | +$210K | 0.07% | 149 |
|
Greenwood Capital Associates's CMD Position: Q2 2021 in Review
Greenwood Capital Associates sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 14,617 shares — an estimated $1.17M sold.
Greenwood Capital Associates first reported a position in CMD in Q4 2015 and held it in 14 quarters. The position peaked at $1.33M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Greenwood Capital Associates reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Greenwood Capital Associates sold 14,617 Cantel Medical Corporation shares in Q2 2021, an estimated $1.17M.
- Greenwood Capital Associates first reported a position in Cantel Medical Corporation in Q4 2015 and held it in 14 quarters.
- Greenwood Capital Associates's Cantel Medical Corporation position peaked at $1.33M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Greenwood Capital Associates's 13F filing for Q2 2021, filed 16 Aug 2021.